Literature DB >> 22035179

The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.

Andrew J Agnew1, Emma Robinson, Carmel M McVicar, Adam P Harvey, Imran H A Ali, Jennifer E Lindsay, Denise M McDonald, Brian D Green, David J Grieve.   

Abstract

BACKGROUND AND
PURPOSE: Obestatin is a recently discovered gastrointestinal peptide with established metabolic actions, which is linked to diabetes and may exert cardiovascular benefits. Here we aimed to investigate the specific effects of obestatin on vascular relaxation. EXPERIMENTAL APPROACH: Cumulative relaxation responses to obestatin peptides were assessed in rat isolated aorta and mesenteric artery (n≥ 8) in the presence and absence of selective inhibitors. Complementary studies were performed in cultured bovine aortic endothelial cells (BAEC). KEY
RESULTS: Obestatin peptides elicited concentration-dependent relaxation in both aorta and mesenteric artery. Responses to full-length obestatin(1-23) were greater than those to obestatin(1-10) and obestatin(11-23). Obestatin(1-23)-induced relaxation was attenuated by endothelial denudation, l-NAME (NOS inhibitor), high extracellular K(+) , GDP-β-S (G-protein inhibitor), MDL-12,330A (adenylate cyclase inhibitor), wortmannin (PI3K inhibitor), KN-93 (CaMKII inhibitor), ODQ (guanylate cyclase inhibitor) and iberiotoxin (BK(Ca) blocker), suggesting that it is mediated by an endothelium-dependent NO signalling cascade involving an adenylate cyclase-linked GPCR, PI3K/PKB, Ca(2+) -dependent eNOS activation, soluble guanylate cyclase and modulation of vascular smooth muscle K(+) . Supporting data from BAEC indicated that nitrite production, intracellular Ca(2+) and PKB phosphorylation were increased after exposure to obestatin(1-23). Relaxations to obestatin(1-23) were unaltered by inhibitors of candidate endothelium-derived hyperpolarizing factors (EDHFs) and combined SK(Ca) /IK(Ca) blockade, suggesting that EDHF-mediated pathways were not involved. CONCLUSIONS AND IMPLICATIONS: Obestatin produces significant vascular relaxation via specific activation of endothelium-dependent NO signalling. These actions may be important in normal regulation of vascular function and are clearly relevant to diabetes, a condition characterized by endothelial dysfunction and cardiovascular complications.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22035179      PMCID: PMC3415657          DOI: 10.1111/j.1476-5381.2011.01761.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat.

Authors:  ShreeRanga Nagaraj; Muthukumar S Peddha; Uma V Manjappara
Journal:  Biochem Biophys Res Commun       Date:  2007-12-17       Impact factor: 3.575

2.  Obestatin conformational features: a strategy to unveil obestatin's biological role?

Authors:  Mario Scrima; Pietro Campiglia; Cinzia Esposito; Isabel Gomez-Monterrey; Ettore Novellino; Anna Maria D'Ursi
Journal:  Biochem Biophys Res Commun       Date:  2007-09-19       Impact factor: 3.575

3.  Obestatin acts in brain to inhibit thirst.

Authors:  Willis K Samson; Meghan M White; Christopher Price; Alastair V Ferguson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-24       Impact factor: 3.619

4.  Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.

Authors:  Xiaoya Qi; Ling Li; Gangyi Yang; Jianlei Liu; Ke Li; Yi Tang; Hua Liou; Guenther Boden
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

Review 5.  Obestatin--a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility.

Authors:  G Gourcerol; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2007-03       Impact factor: 3.598

6.  Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice.

Authors:  B D Green; N Irwin; P R Flatt
Journal:  Peptides       Date:  2007-02-12       Impact factor: 3.750

7.  Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract.

Authors:  A K Bassil; Y Häglund; J Brown; T Rudholm; P M Hellström; E Näslund; K Lee; G J Sanger
Journal:  Br J Pharmacol       Date:  2006-11-27       Impact factor: 8.739

8.  Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake".

Authors:  N Chartrel; R Alvear-Perez; J Leprince; X Iturrioz; A Reaux-Le Goazigo; V Audinot; P Chomarat; F Coge; O Nosjean; M Rodriguez; J P Galizzi; J A Boutin; H Vaudry; C Llorens-Cortes
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

9.  Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans.

Authors:  Marietta Anderwald-Stadler; Michael Krebs; Miriam Promintzer; Martina Mandl; Martin G Bischof; Peter Nowotny; Thomas Kästenbauer; Anton Luger; Rudolf Prager; Christian Anderwald
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-04       Impact factor: 4.310

Review 10.  Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

Authors:  Sandra J Hamilton; Gerard T Chew; Gerald F Watts
Journal:  Diab Vasc Dis Res       Date:  2007-06       Impact factor: 3.291

View more
  14 in total

1.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

2.  Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors.

Authors:  E E Khirazova; M V Maslova; E S Motorykina; D A Frid; A V Graf; A S Maklakova; N A Sokolova; A A Kamenskii
Journal:  Dokl Biol Sci       Date:  2014-01-03

3.  Ghrelin-related peptides exert protective effects in the cerebral circulation of male mice through a nonclassical ghrelin receptor(s).

Authors:  Jacqueline M Ku; Zane B Andrews; Tom Barsby; Alex Reichenbach; Moyra B Lemus; Grant R Drummond; Mark W Sleeman; Sarah J Spencer; Christopher G Sobey; Alyson A Miller
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

4.  Comparative in vitro effects of calcineurin inhibitors on functional vascular relaxations of both rat thoracic and abdominal aorta.

Authors:  Ashok Jadhav; Venkat Gopalakrishnan; Ahmed Shoker
Journal:  Adv Pharmacol Sci       Date:  2013-06-18

5.  Relevance of plasma obestatin and early arteriosclerosis in patients with type 2 diabetes mellitus.

Authors:  Peng-Ying Gu; Dong-Mei Kang; Wei-Dong Wang; Yan Chen; Zhi-Hong Zhao; Hui Zheng; Shan-Dong Ye
Journal:  J Diabetes Res       Date:  2013-11-17       Impact factor: 4.011

6.  Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics.

Authors:  Brian D Green; Stewart F Graham; Elaine Cowan; Praveen Kumar; Kerry J Burch; David J Grieve
Journal:  Metabolomics       Date:  2016-07-05       Impact factor: 4.290

Review 7.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

Review 8.  The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa.

Authors:  Kvido Smitka; Hana Papezova; Karel Vondra; Martin Hill; Vojtech Hainer; Jara Nedvidkova
Journal:  Int J Endocrinol       Date:  2013-09-09       Impact factor: 3.257

9.  Low serum concentration of obestatin as a predictor of mortality in maintenance hemodialysis patients.

Authors:  Ilia Beberashvili; Inna Sinuani; Ada Azar; Hadas Kadoshi; Gregory Shapiro; Leonid Feldman; Judith Sandbank; Zhan Averbukh
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

10.  The octopamine receptor Octβ2R regulates ovulation in Drosophila melanogaster.

Authors:  Junghwa Lim; Paul R Sabandal; Ana Fernandez; John Martin Sabandal; Hyun-Gwan Lee; Peter Evans; Kyung-An Han
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.